U.S. Semiconductors Stock News

Teekay ( NYSE:TK ) Second Quarter 2025 Results Key Financial Results Revenue: US$231.7m (down 29% from 2Q 2024). Net...

Skyworks Solutions, Inc.'s ( NASDAQ:SWKS ) price-to-earnings (or "P/E") ratio of 24.7x might make it look like a sell...

Cable One ( NYSE:CABO ) Second Quarter 2025 Results Key Financial Results Revenue: US$381.1m (down 3.4% from 2Q 2024...

Cinemark Holdings ( NYSE:CNK ) Second Quarter 2025 Results Key Financial Results Revenue: US$940.5m (up 28% from 2Q...

Anyone interested in Esquire Financial Holdings, Inc. ( NASDAQ:ESQ ) should probably be aware that the Independent...

The Badger Meter, Inc. ( NYSE:BMI ) share price has fared very poorly over the last month, falling by a substantial...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Four Seasons Education (Cayman) Inc. ( NYSE:FEDU ) shares have continued their recent momentum with a 28% gain in the...

Let's talk about the popular Ferguson Enterprises Inc. ( NYSE:FERG ). The company's shares received a lot of attention...

X Financial ( NYSE:XYF ) shares have retraced a considerable 25% in the last month, reversing a fair amount of their...

Despite an already strong run, BT Brands, Inc. ( NASDAQ:BTBD ) shares have been powering on, with a gain of 26% in the...

Kinsale Capital Group recently reported second-quarter results, with revenue of US$469.81 million and net income of US$134.12 million, both higher than the same quarter last year; for the first half of the year, the company achieved US$893.21 million in revenue and US$223.35 million in net income. The company’s continued share repurchases alongside strong earnings suggest management’s confidence in future prospects, even as analysts predict a moderation in near-term earnings growth compared...

XP Inc. recently received upgrades from major analysts and announced a share repurchase program, canceling over 12 million treasury shares to reduce its total outstanding share count. This move signals management's intent to enhance shareholder value and reflects growing confidence from both the company and covering analysts. We'll explore how the new share repurchase program could influence XP Inc.'s earnings outlook and overall investment narrative. Rare earth metals are the new gold rush...

W. R. Berkley recently reported second-quarter 2025 results, detailing revenue of US$3.67 billion and net income of US$401.29 million, alongside Berkley One Classics' policy and pricing enhancements for collectors in Georgia. These developments underscore the company’s continued emphasis on specialty insurance innovation and customer-focused updates in support of long-term growth initiatives. Let’s consider how this combination of strong financial results and expanded specialty offerings...

Woodward, Inc. recently reported quarterly results showing sales of US$915.45 million and net income of US$108.45 million, with full-year sales and earnings guidance raised but a reduced free cash flow outlook due to increased working capital needs. This mix of operational improvement paired with a more cautious free cash flow view highlights the balancing act companies face between supporting growth and maintaining financial flexibility. We'll explore how Woodward's strong aerospace segment...

Paramount Global recently reported its second quarter 2025 earnings, showing sales of US$6.85 billion and a return to profitability with net income of US$57 million after a very large loss in the same period last year. A standout detail from the results was the continued strength of the Paramount+ streaming segment, which reported subscriber and revenue growth despite overall industry challenges. We'll explore how Paramount+'s robust subscriber and revenue growth impacts the company's...

Keurig Dr Pepper Inc. recently reported second quarter and half-year results, showing increased sales of US$4.16 billion and net income of US$547 million for the quarter ended June 30, 2025, compared to the same period last year. A key insight is that despite incurring substantial non-recurring expenses, the company reaffirmed its full-year earnings guidance, highlighting management's confidence in sustained growth and core business strength. With management reiterating its mid-single-digit...

Boston Scientific reported its second quarter 2025 results, with revenue rising to US$5.06 billion and net income increasing to US$797 million, alongside much lower intangible asset impairment charges compared to the previous year. Alongside this performance, the company issued optimistic guidance for both third quarter and full-year 2025 sales and earnings, reflecting management’s confidence in the business trajectory and demand for its advanced therapies. We'll examine how Boston...

In July 2025, Northrop Grumman launched partnerships with Merlin and Red 6 to integrate advanced autonomy solutions onto its new Beacon testbed, supporting U.S. government autonomy initiatives and expanding open-access validation of mission systems. These collaborations are designed to accelerate operational testing and development of software-driven, autonomous defense platforms, positioning Northrop Grumman at the forefront of next-generation uncrewed systems innovation. We'll review how...

Merck & Co. recently reported second quarter results reflecting slightly lower year-over-year earnings and sales, alongside a revised 2025 full-year sales guidance of US$64.3 billion to US$65.3 billion due to foreign exchange impacts and softer demand in key products. Despite these operational challenges, the company advanced its oncology portfolio with Health Canada approval for KEYTRUDA in cervical cancer and reinforced its commitment to shareholders through a fourth quarterly dividend and...

CRISPR Therapeutics (CRSP) recently announced significant developments in its in vivo cardiovascular disease programs, notably CTX310 and CTX320, which may have contributed to the company's 47% share price increase over the last quarter. The company's inclusion in multiple indices further enhances its market presence, potentially impacting investor interest positively. Meanwhile, CRISPR reported a net loss in its Q1 earnings, although revenue increased year-over-year. Despite a volatile...

Recursion Pharmaceuticals (RXRX) experienced a price increase of 9% over the past month, positioning it against the backdrop of a broader market decline driven by geopolitical tensions and weak jobs data. Despite these broader market headwinds, which saw significant tech stock declines due to tariff concerns and disappointing economic indicators, Recursion managed to outperform. The company’s stock movement appeared isolated from these wider trends, which implies internal factors or...

Rivian Automotive (RIVN) has been actively expanding its operations, with recent developments including the establishment of a new East Coast headquarters in Atlanta and a new service center in Quebec. These efforts reflect the company's focus on enhancing its presence and infrastructure. However, RIVN's stock price saw a 3.8% decline over the past month. This decline aligns with broader market trends, as stocks experienced downturns due to weak job reports and heightened tariff concerns,...

Old Dominion Freight Line (ODFL) reported disappointing second-quarter earnings, with sales and net income both declining compared to the previous year. Despite affirmative news about a 7.7% dividend increase and share repurchase activity, ODFL saw its stock fall by 10.23% over the past quarter. This decline mirrored broader market concerns, as stocks generally fell due to weak job reports and renewed tariff worries. Old Dominion's on-market total return decline may have been amplified by...